These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33939124)

  • 1. Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection.
    Selinger C; Rahmoun M; Murall CL; Bernat C; Boué V; Bonneau M; Graf C; Grasset S; Groc S; Reynes J; Hirtz C; Jacobs N; Alizon S
    Immunol Res; 2021 Jun; 69(3):255-263. PubMed ID: 33939124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
    Buckley N; Huber A; Lo Y; Castle PE; Kemal K; Burk RD; Strickler HD; Einstein MH; Young M; Anastos K; Herold BC
    Am J Reprod Immunol; 2016 Feb; 75(2):146-54. PubMed ID: 26685115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slumbering mucosal immune response in the cervix of human papillomavirus DNA-positive and -negative women.
    Brismar Wendel S; Kaldensjö T; Peterson P; Andersson S; Broliden K; Hirbod T
    Int J Oncol; 2010 Dec; 37(6):1565-73. PubMed ID: 21042726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study.
    Murall CL; Rahmoun M; Selinger C; Baldellou M; Bernat C; Bonneau M; Boué V; Buisson M; Christophe G; D'Auria G; Taroni F; Foulongne V; Froissart R; Graf C; Grasset S; Groc S; Hirtz C; Jaussent A; Lajoie J; Lorcy F; Picot E; Picot MC; Ravel J; Reynes J; Rousset T; Seddiki A; Teirlinck M; Tribout V; Tuaillon É; Waterboer T; Jacobs N; Bravo IG; Segondy M; Boulle N; Alizon S
    BMJ Open; 2019 Jun; 9(6):e025129. PubMed ID: 31189673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
    Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature.
    Pattyn J; Van Keer S; Tjalma W; Matheeussen V; Van Damme P; Vorsters A
    Papillomavirus Res; 2019 Dec; 8():100185. PubMed ID: 31494291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus (HPV) DNA Detection Using Self-Sampling Devices in Women Undergoing Long Term Immunosuppressive Therapy.
    Wielgos A; Pietrzak B; Sikora M; Martirosian G; Suchonska B; Gozdowska J; Oldakowska-Jedynak U; Jabiry-Zieniewicz Z; Durlik M; Rudnicka L; Wielgos M
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32872666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection.
    Behbahani H; Walther-Jallow L; Klareskog E; Baum L; French AL; Patterson BK; Garcia P; Spetz AL; Landay A; Andersson J
    J Acquir Immune Defic Syndr; 2007 May; 45(1):9-19. PubMed ID: 17356467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition.
    Liebenberg LJP; McKinnon LR; Yende-Zuma N; Garrett N; Baxter C; Kharsany ABM; Archary D; Rositch A; Samsunder N; Mansoor LE; Passmore JS; Abdool Karim SS; Abdool Karim Q
    Nat Commun; 2019 Nov; 10(1):5227. PubMed ID: 31745084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs in Young Women in the United States Between 2003 and 2012.
    Tarney CM; Klaric J; Beltran T; Pagan M; Han J
    Obstet Gynecol; 2016 Dec; 128(6):1241-1247. PubMed ID: 27824760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection.
    Bard E; Riethmuller D; Meillet D; Prétet JL; Schaal JP; Mougin C; Seillès E
    Viral Immunol; 2004; 17(3):381-9. PubMed ID: 15357904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
    Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A type-specific study of human papillomavirus prevalence in cervicovaginal samples in three different Spanish regions.
    Gomez-Roman JJ; Echevarria C; Salas S; González-Morán MA; Perez-Mies B; García-Higuera I; Nicolás Martínez M; Val-Bernal JF
    APMIS; 2009 Jan; 117(1):22-7. PubMed ID: 19161533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women.
    D'Souza G; Burk RD; Zhong Y; Minkoff H; Massad LS; Xue X; Watts DH; Anastos K; Palefsky JM; Levine AM; Colie C; Castle PE; Strickler HD
    Int J Cancer; 2012 Sep; 131(6):1472-8. PubMed ID: 22120980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
    Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
    J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women.
    Hwang LY; Scott ME; Ma Y; Moscicki AB
    Am J Reprod Immunol; 2015 Sep; 74(3):228-36. PubMed ID: 25989718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types.
    Huang X; Li C; Li F; Zhao J; Wan X; Wang K
    Int J Cancer; 2018 Aug; 143(3):621-634. PubMed ID: 29479697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and Chlamydia trachomatis in oral and genital mucosa of women with normal and abnormal cervical cytology.
    Mosmann JP; Zayas S; Kiguen AX; Venezuela RF; Rosato O; Cuffini CG
    BMC Infect Dis; 2021 May; 21(1):422. PubMed ID: 33952203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
    Ermel AC; Shew ML; Weaver BA; Qadadri B; Denski C; Tu W; Tong Y; Fortenberry JD; Brown DR
    Sex Transm Infect; 2014 Feb; 90(1):64-9. PubMed ID: 24031030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cytokine levels and human papillomavirus infection at the cervix in rural Nigerian women.
    Mbulaiteye SM; Kemp T; Gage JC; Ajenifuja KO; Kiruthu C; Wentzensen NA; Adepiti C; Wacholder S; Burk RD; Schiffman M; Pinto L
    Cytokine; 2013 Oct; 64(1):146-51. PubMed ID: 23972725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.